Key Highlights
- Third-quarter 2026 Revenue was USD 3.3 million, against USD 17.7 million in the second quarter.
- Net loss was USD 13.5 million; Adjusted EBITDA loss was USD 8.8 million.
- Definitive agreements were signed to acquire about 77% of DEAG.
- Cash and cash equivalents were USD 12.1 million at September 30, 2026.
Enhanced Group (NYSE:ENHA) reported third-quarter 2026 revenue of USD 3.3 million, against an estimate of USD 8.53 million, with no revenue in the prior-year period. The sports, live entertainment and performance products company said the results reflect the stand-alone Business of Enhanced Games and Live Enhanced, and that on November 5, 2026 it announced definitive agreements to acquire an approximately 77% controlling interest in DEAG Deutsche Entertainment AG.
Quarterly Results
Revenue was USD 3.3 million, against USD 17.7 million in the second quarter. The company said second-quarter revenue was driven primarily by the inaugural Enhanced Games held in May, while third-quarter revenue reflects the acceleration of Live Enhanced telehealth sales and continued recognition under its sponsorship agreements.
Games, athletes and event operating costs were USD 2.7 million, against USD 52.0 million in the second quarter and USD 1.3 million in the prior-year period. The company said third-quarter costs consisted primarily of contracted athlete compensation. Selling, general and administrative expenses were USD 12.7 million, against USD 16.6 million in the second quarter and USD 4.2 million a year earlier, and included USD 3.1 million of non-cash Rumble Marketing expense.
Loss from operations was USD 13.5 million, against USD 61.9 million in the second quarter and USD 5.9 million in the prior-year period. Net loss was USD 13.5 million. Adjusted EBITDA, a non-GAAP measure, was a loss of USD 8.8 million, against a loss of USD 42.7 million in the second quarter and a loss of USD 3.8 million a year earlier.
DEAG Acquisition and PIPE Financing
DEAG is a Berlin-headquartered live entertainment and ticketing company that operates in seven core European markets and stages approximately 6,000 live events a year. The transaction is all-stock, with no cash consideration. Enhanced Group plans to issue approximately 11 million shares of Class A common stock at USD 8.00 per share, at an exchange ratio of approximately one Enhanced share for 1.7 DEAG shares. The company states the agreed value of EUR 4.00 per DEAG share values 100% of DEAG's Equity at approximately USD 115 million and implies an Enterprise value of approximately USD 139 million.
Closing is envisaged for the first quarter of 2027. Following closing, the company projects combined 2027 revenue of approximately USD 670 million and combined Adjusted EBITDA of approximately USD 26 million. It states these combined figures are illustrative estimates prepared by the company on the basis of publicly available information, and that DEAG did not participate in their preparation.
Concurrently, the company entered into a securities purchase agreement for a USD 15 million private Investment in public equity, which is due to close alongside the DEAG acquisition and add approximately 2.1 million Class A shares.
Cash, Operations and Corporate Updates
Cash and cash equivalents were USD 12.1 million at September 30, 2026, against USD 19.6 million at June 30, 2026 and USD 25.3 million at December 31, 2025. The company states this figure excludes the USD 15 million PIPE and USD 20 million in sponsorship amounts due at the end of the year, comprising USD 10 million of cash under the Zoop title sponsorship arrangement and USD 10 million in Rezolve shares unlocked in December 2026.
Operational updates included the launch of the Beta version of Enhanced OS, an AI-powered platform that combines medical records, biomarker testing and wearable data into individualized health plans, with licensed physicians retaining clinical decision-making authority. The company also added Modafinil and six peptides to its Live Enhanced telehealth platform, all available by prescription.
The company completed the third and final closing of its approximately USD 50 million private Placement on August 14, 2026, and effected a one-for-ten Reverse Stock Split on October 29, 2026. It stated that approximately 13.7 million Class A shares are outstanding, that only Class A shares carry economic ownership, and that its market Capitalization was roughly USD 110 million based on a closing price of USD 8.05. Chief Financial Officer Sid Banthiya said the company projects 2027 telehealth revenue well into the double-digit millions.


_11_20_2026_14_55_23_118425.jpg)



Please wait processing your request...